A health care worker in the U.S. state of Alaska has been hospitalized with a severe allergic reaction after receiving a coronavirus vaccine from BioNTech and Pfizer. It was reported by The New York Times on Tuesday, citing sources.
It is noted that the health care worker’s condition is assessed as stable. His reaction to the vaccine was similar to that seen in two health workers after vaccinations in the United Kingdom last week.
It is not known whether the employee in Alaska was allergic to the medication, the newspaper specifies.
A COVID-19 vaccination campaign was launched in the U.S. on Dec. 14. The U.S. Centers for Disease Control and Prevention (CDC) recommended using a vaccine manufactured by Pfizer and BioNTech, both American and German.
It is expected that Moderna’s vaccine may soon receive emergency approval. On the same day, U.S. President Donald Trump announced that the first vaccination against coronavirus infection had been given in the United States. At the same time, the American leader stressed that so far he has no plans to be vaccinated against COVID-19.
On December 8, it became known that six participants died during vaccine trials by Pfizer and BioNTech: two deaths in the vaccinated group, four in the placebo group.
In October, research on another American vaccine from Johnson & Johnson was halted because of an unknown disease in one of the participants. The first batches of the Johnson & Johnson vaccine were expected to be available in early 2021.